> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Hearing on HCT/P Draft Guidances
- URL: https://www.fdaweb.com/hearing-on-hct-p-draft-guidances/
- Published: 2016-04-22T12:00:00.000Z
- Updated: 2026-09-14T20:56:52.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5135463

*Federal Register* Notice: FDA will hold a two-day public hearing 9/12-13 to obtain input on four draft guidance documents relating to the regulation of human cells, tissues, and cellular and tissue-based products (HCT/Ps). The draft guidances are: Same Surgical Procedure Exception under 21 CFR 1271.15(b): Questions and Answers Regarding the Scope of the Exception, Minimal Manipulation of Human Cells, Tissues, and Cellular and Tissue-Based Products, Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) from Adipose Tissue: Regulatory Considerations, and Homologous Use of Human Cells, Tissues, and Cellular and Tissue-Based Products. he hearing will be held from 9 a.m. to 5 p.m. on both days, but the 9/13 hearing on may be extended or end early depending on the number of speakers scheduled. Persons (including FDA employees) seeking to view the hearing via a live Webcast are not required to register. The hearing will be held at the National Institutes of Health, 9000 Rockville Pike, Bldg. 10, Masur Auditorium, Bethesda, MD. Contact **Lori Jo Churchyard**, (240) 402-7911, [lori.olsenchurchyard@fda.hhs.gov](mailto:lori.olsenchurchyard@fda.hhs.gov). To view this notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2016-04-22/pdf/2016-09372.pdf?ref=fdaweb.com).